These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 36924905)
21. Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells. Li P; Diab S; Yu M; Adams J; Islam S; Basnet SK; Albrecht H; Milne R; Wang S Oncotarget; 2016 Aug; 7(35):56811-56825. PubMed ID: 27462781 [TBL] [Abstract][Full Text] [Related]
22. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670 [TBL] [Abstract][Full Text] [Related]
23. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells. Chen L; Hu N; Wang C; Zhao H Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363 [TBL] [Abstract][Full Text] [Related]
24. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo. Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447 [TBL] [Abstract][Full Text] [Related]
25. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477. Mallick DJ; Soderquist RS; Bates D; Eastman A Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196 [TBL] [Abstract][Full Text] [Related]
27. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms. Wang S; Wang Z; Grant S Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556 [TBL] [Abstract][Full Text] [Related]
28. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. Yang C; Boyson CA; Di Liberto M; Huang X; Hannah J; Dorn DC; Moore MA; Chen-Kiang S; Zhou P Cancer Res; 2015 May; 75(9):1838-45. PubMed ID: 25744718 [TBL] [Abstract][Full Text] [Related]
29. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-beta-D-arabinofuranosylcytosine. Wang Z; Wang S; Fisher PB; Dent P; Grant S Differentiation; 2000 Aug; 66(1):1-13. PubMed ID: 10997587 [TBL] [Abstract][Full Text] [Related]
30. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells. Chen YJ; Wang JJ; Chang LS Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174 [TBL] [Abstract][Full Text] [Related]
31. Carboxyl Group-Modified Myoglobin Induces TNF-α-Mediated Apoptosis in Leukemia Cells. Lee YC; Chiou JT; Wang LJ; Shi YJ; Chen YJ; Chang LS Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145287 [TBL] [Abstract][Full Text] [Related]
32. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents. Vrana JA; Cleaveland ES; Eastman A; Craig RW Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109 [TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA DANCR confers cytarabine resistance in acute myeloid leukemia by activating autophagy via the miR-874-3P/ATG16L1 axis. Zhang H; Liu L; Chen L; Liu H; Ren S; Tao Y Mol Oncol; 2021 Apr; 15(4):1203-1216. PubMed ID: 33638615 [TBL] [Abstract][Full Text] [Related]
34. ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells. Lee YC; Wang LJ; Huang CH; Shi YJ; Chang LS Cancer Lett; 2018 Sep; 432():191-204. PubMed ID: 29913235 [TBL] [Abstract][Full Text] [Related]
35. GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia. Zhou C; Du J; Zhao L; Liu W; Zhao T; Liang H; Fang P; Zhang K; Zeng H Cell Death Dis; 2021 Mar; 12(3):231. PubMed ID: 33658491 [TBL] [Abstract][Full Text] [Related]
36. The Association Between p38 MAPK-Mediated TNF-α/TNFR2 up-Regulation and 2-(4-Aminophenyl)-7-Methoxybenzothiazole-Induced Apoptosis in Human Leukemia U937 Cells. Huang CH; Chen YJ; Chao TY; Liu WH; Changchien JJ; Hu WP; Chang LS J Cell Physiol; 2016 Jan; 231(1):130-41. PubMed ID: 26059963 [TBL] [Abstract][Full Text] [Related]
37. Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia. Abraham A; Varatharajan S; Abbas S; Zhang W; Shaji RV; Ahmed R; Abraham A; George B; Srivastava A; Chandy M; Mathews V; Balasubramanian P Pharmacogenomics; 2012 Feb; 13(3):269-82. PubMed ID: 22304580 [TBL] [Abstract][Full Text] [Related]
39. p38 MAPK/PP2Acα/TTP pathway on the connection of TNF-α and caspases activation on hydroquinone-induced apoptosis. Liu WH; Chou WM; Chang LS Carcinogenesis; 2013 Apr; 34(4):818-27. PubMed ID: 23288922 [TBL] [Abstract][Full Text] [Related]
40. Potentiation of 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01). Tang L; Boise LH; Dent P; Grant S Biochem Pharmacol; 2000 Nov; 60(10):1445-56. PubMed ID: 11020446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]